Discover 884 paid clinical trials in Daytona Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 884
Active & Responsive
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for
Parkinson Disease
Location: Orlando FL, Tampa FL, Boca Raton FL, Hallandale FL,
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All
Age: 30 - 70+
Code: NCT07432958
Phase 2, Recruiting
Active & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for
Obesity, Overweight
Location: Mt. Dora FL, St. Petersburg FL, Atlantis FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07321886
Phase 3, Recruiting
Active & Responsive
Study of DONQ52 in Active Celiac Disease
for
Celiac Disease
Location: Saint Augustine FL, Ocala FL, Jacksonville FL, Tampa FL,
Sponsor: Chugai Pharmaceutical
Sex: All
Age: 18 - 70+
Code: NCT07239336
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Orlando FL, Jacksonville FL, Gainesville FL, Tampa FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase 3, Recruiting
Active & Responsive
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Orlando FL, Jacksonville FL, Clinton NC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05136196
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: Orlando FL, Inverness FL, Tampa FL, University Park FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16 - 70+
Code: NCT06430801
Phase 3, Recruiting
Active & Responsive
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
for
Alzheimer Disease
Location: Orlando FL, Gainesville FL, Tampa FL, Delray Beach FL,
Sponsor: InSightec
Sex: All
Age: 50 - 70+
Code: NCT03671889
Recruiting
Active & Responsive
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
for
Diabetic Nephropathies, Kidney Failure, Chronic,
Location: Orlando FL, St Louis MO, Cleveland OH, The Bronx NY,
Sponsor: Alessandro Doria
Sex: All
Age: 18 - 70+
Code: NCT06217302
Phase 3, Recruiting
Active & Responsive
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Location: Orlando FL, Jacksonville FL, Tampa FL, Clearwater FL,
Sponsor: GT Medical Technologies, Inc.
Sex: All
Age: 0+
Code: NCT04427384
Recruiting
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Cancer, Early Detection of Cancer, Minimal Residual Disease
Location: Orlando FL, Tampa FL, Lake City FL, Fort Myers FL,
Sponsor: Caris Science, Inc.
Sex: All
Age: 18+
Code: NCT01499394
Recruiting
Active & Responsive
Assessment of CCM in HF With Higher Ejection Fraction
for
Heart Failure, Heart Failure With Preserved Ejection Fraction,
Location: Orlando FL, Weston FL, Miami FL, Cutler Bay FL,
Sponsor: Impulse Dynamics
Sex: All
Age: 18+
Code: NCT05064709
Recruiting
Active & Responsive
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
for
Ulcerative Colitis (UC), Crohn's Disease (CD),
Location: Orlando FL, Miami FL, Charlotte NC, Chapel Hill NC,
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18+
Code: NCT07237516
Recruiting
Active & Responsive
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
for
Extensive Stage-small Cell Lung Cancer
Location: Orlando FL, Jacksonville FL, Tampa FL, Birmingham AL,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06362252
Phase 1, Phase 2, Recruiting
Active & Responsive
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for
Platinum-resistant Ovarian Cancer,
Location: Orlando FL, St. Petersburg FL, Sarasota FL,
Sponsor: Genelux Corporation
Sex: Female
Age: 18+
Code: NCT05281471
Phase 3, Recruiting
Active & Responsive
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
for
Myelodysplastic Syndromes
Location: Orlando FL, Jacksonville FL, Tampa FL, Miami FL,